Charles Peterfy

机构：Boca Raton Regional Hospital · ORCID：0000-0001-8277-6328

发表论文 240 篇 · 总被引 17843 次 · h-index 66

代表论文

• Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study (2022 · RMD Open · 被引 104)
• Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT (2021 · Clinical Cancer Research · 被引 32)
• Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study (2024 · RMD Open · 被引 29)
• Inhibition of structural joint damage progression with upadacitinib in rheumatoid arthritis: 1-year outcomes from the SELECT phase 3 program (2021 · Lara D. Veeken · 被引 14)
• Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study (2025 · The Oncologist · 被引 12)
• CSF1 Receptor Inhibition of Tenosynovial Giant Cell Tumor Using Novel Disease-Specific MRI Measures of Tumor Burden (2022 · Future Oncology · 被引 12)